H5N1 milk detection study
Part of Infections, Lungs & breathing clinical trials.
This study looks for the H5N1 virus in the milk of healthy adults. If you are generally healthy and between 18 and 64, you may be able to help by providing milk samples to see if the virus can be detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old
- Have a body mass index (BMI) of 35 or less
- Be in good general health
- Not have any symptoms of a cold, flu, or pink eye in the last week
- Not be pregnant or breastfeeding
- Not have a history of allergy or intolerance to milk or milk alternatives
- Not have drunk raw (unpasteurized) milk in the last 14 days
- Not have worked on a farm with sick animals in the last 14 days
- Have never received an H5N1 (bird flu) vaccine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This study tests an experimental flu vaccine designed to protect against the H5N8 bird flu virus. It is given with an ingredient that may boost the immune response. The study will check if the vaccine is safe and how well it triggers the body's defenses.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.